Works matching IS 09395555 AND DT 2018 AND VI 97 AND IP 5


Results: 28
    1
    2

    Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.

    Published in:
    2018
    By:
    • on behalf of the CETLAM and PETHEMA groups;
    • CETLAM and PETHEMA groups;
    • Boluda, Blanca;
    • Rodríguez-Veiga, Rebeca;
    • Moscardó, Federico;
    • Martínez-Cuadrón, David;
    • Cordón, Lourdes;
    • Sempere, Amparo;
    • Montesinos, Pau;
    • Sanz, Miguel A.;
    • Garrido, Ana;
    • Benavente, Celina;
    • Pérez-Simón, José Antonio;
    • Martínez, Pilar;
    • Jiménez-Ubieto, Ana;
    • Bergua, Juan;
    • Prieto-Delgado, Julio;
    • Esteve, Jordi;
    • Díaz-Beyá, Marina;
    • Vives, Susana
    Publication type:
    journal article
    3
    4
    5
    6
    7
    8

    Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL).

    Published in:
    2018
    By:
    • on the behalf of the SEIFEM group (Sorveglianza Epidemiologica Infezioni Fungine in Ematologia);
    • Di Blasi, Roberta;
    • Dragonetti, Giulia;
    • Cesarini, Monica;
    • Giordano, Antonio;
    • Pagano, Livio;
    • Candoni, Anna;
    • Cesaro, Simone;
    • Delia, Mario;
    • Fanci, Rosa;
    • Farina, Francesca;
    • Garzia, Mariagrazia;
    • Martino, Bruno;
    • Melillo, Lorella;
    • Nadali, Gianpaolo;
    • Perriello, Vincenzo;
    • Cattaneo, Chiara;
    • Picardi, Marco;
    • Quinto, Angela Maria;
    • Salutari, Prassede
    Publication type:
    journal article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Prognostic risk models for transplant decision-making in myelofibrosis.

    Published in:
    2018
    By:
    • Hernández-Boluda, Juan-Carlos;
    • Gómez, Montse;
    • Estrada, Natalia;
    • García-Gutiérrez, Valentín;
    • Fox, María-Laura;
    • Payer, Angel;
    • Kerguelen, Ana;
    • Cuevas, Beatriz;
    • Durán, María-Antonia;
    • Ramírez, María-José;
    • Gómez-Casares, María-Teresa;
    • Mata-Vázquez, María-Isabel;
    • Pereira, Arturo;
    • Mora, Elvira;
    • Correa, Juan-Gonzalo;
    • Cervantes, Francisco;
    • Alvarez-Larrán, Alberto;
    • Ferrer-Marín, Francisca;
    • Raya, José-María;
    • Martínez-López, Joaquín
    Publication type:
    journal article
    22
    23
    24

    Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma.

    Published in:
    2018
    By:
    • Fouquet, Guillemette;
    • Petillon, Marie Odile;
    • Facon, Thierry;
    • Kolb, Brigitte;
    • Stoppa, Anne-Marie;
    • Brechiniac, Sabine;
    • Rodon, Philippe;
    • Dib, Mamoun;
    • Tiab, Mourad;
    • Richez, Valentine;
    • Araujo, Carla;
    • Wetterwald, Marc;
    • Garderet, Laurent;
    • Karlin, Lionel;
    • Royer, Bruno;
    • Perrot, Aurore;
    • Benboubker, Lotfi;
    • Decaux, Olivier;
    • Escoffre-Barbe, Martine;
    • Moreau, Philippe
    Publication type:
    journal article
    25
    26
    27

    A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.

    Published in:
    2018
    By:
    • on behalf of the CETLAM and PETHEMA groups;
    • CETLAM and PETHEMA groups;
    • Boluda, Blanca;
    • Rodríguez-Veiga, Rebeca;
    • Moscardó, Federico;
    • Martínez-Cuadrón, David;
    • Cordón, Lourdes;
    • Sempere, Amparo;
    • Montesinos, Pau;
    • Sanz, Miguel A.;
    • Garrido, Ana;
    • Benavente, Celina;
    • Pérez-Simón, José Antonio;
    • Martínez, Pilar;
    • Jiménez-Ubieto, Ana;
    • Bergua, Juan;
    • Prieto-Delgado, Julio;
    • Esteve, Jordi;
    • Díaz-Beyá, Marina;
    • Vives, Susana
    Publication type:
    journal article
    28